<DOC>
	<DOCNO>NCT01031277</DOCNO>
	<brief_summary>The purpose study establish proportion patient lipid-lowering pharmacological treatment reach LDL-C goal accord NCEP ATP III/updated 2004 NCEP ATP III guideline , overall country , establish proportion patient lipid-lowering pharmacological treatment reach LDL-C goal accord NCEP ATP III/updated 2004 NCEP ATP III follow sub-populations : - Primary/secondary prevention patient . - Patients metabolic syndrome ( accord NCEP III definition ) . And establish proportion patient lipid-lowering pharmacological treatment reach LDL-C goal accord Third Joint European Task Force guidelines/national guideline , survey population follow sub-populations : - Primary/secondary prevention patient . - Patients metabolic syndrome .</brief_summary>
	<brief_title>Centralized Pan-Middle East Survey Under-treatment Hypercholesterolemia , Sub-study Gulf States</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<criteria>Race On lipidlowering drug treatment least 3 month , dose change minimum 6 week . Subject must sign informed consent Subjects unwilling unable provide inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>Hypercholesterolemia</keyword>
	<keyword>Update NCEP ATP111</keyword>
	<keyword>Survey</keyword>
</DOC>